Trial intelligence / Profile preview

Phase II basket study of larotrectinib in adult patients with NTRK fusion-positive tumors

CTR20190625Phase 2Completed

Sponsor

Bayer

Start

May 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1